Ultra-late recurrence of gastrointestinal stromal tumour: case report and literature review.

Ryan S. Turley, Peter D. Peng, Srinevas K. Reddy, Andrew S. Barbas, David A. Geller, J. Wallis Marsh, Allan Tsung, Timothy M. Pawlik, Bryan M. Clary, Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer. ,vol. 118, pp. 3571- 3578 ,(2012) , 10.1002/CNCR.26650

Ihor Pidhorecky, Richard T. Cheney, William G. Kraybill, John F. Gibbs, Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Annals of Surgical Oncology. ,vol. 7, pp. 705- 712 ,(2000) , 10.1007/S10434-000-0705-6

Ronan A. Cahill, Didier Mutter, Charles Bailey, Diego Varela, Agnes Neuville, Jacques Marescaux, Primary resection of late, isolated secondary GIST. Journal of Clinical Gastroenterology. ,vol. 43, pp. 288- 289 ,(2009) , 10.1097/MCG.0B013E31815DD492

Michael T. Mazur, H. Brent Clark, Gastric stromal tumors. Reappraisal of histogenesis. The American Journal of Surgical Pathology. ,vol. 7, pp. 507- 519 ,(1983) , 10.1097/00000478-198309000-00001

Alessandro Ginori, Francesco Scaramuzzino, Stefania Marsili, Sergio Tripodi, Late hepatic metastasis from a duodenal gastrointestinal stromal tumor (29 years after surgery): report of a case and review of the literature. International Journal of Surgical Pathology. ,vol. 23, pp. 317- 321 ,(2015) , 10.1177/1066896915573571

Gurpreet Lamba, Ridhi Gupta, Byung Lee, Samir Ambrale, Delong Liu, Current management and prognostic features for gastrointestinal stromal tumor (GIST). Experimental hematology & oncology. ,vol. 1, pp. 14- 14 ,(2012) , 10.1186/2162-3619-1-14

Christopher L. Corless, Karla V. Ballman, Cristina R. Antonescu, Violetta Kolesnikova, Robert G. Maki, Peter W.T. Pisters, Martin E. Blackstein, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, Margaret von Mehren, Shreyaskumar Patel, Martin D. McCarter, Kouros Owzar, Ronald P. DeMatteo, Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial Journal of Clinical Oncology. ,vol. 32, pp. 1563- 1570 ,(2014) , 10.1200/JCO.2013.51.2046

In Yong Whang, Kyung-Jin Seo, Hee Yeon Kim, Chang Wook Kim, Hye Sung Won, A huge necrotic liver mass in a 45-year-old woman: delayed hepatic metastasis of a gastrointestinal stromal tumor. The Korean Journal of Internal Medicine. ,vol. 32, pp. 378- 379 ,(2017) , 10.3904/KJIM.2015.397

Michael C. Heinrich, Cathryn Rankin, Charles D. Blanke, George D. Demetri, Ernest C. Borden, Christopher W. Ryan, Margaret von Mehren, Martin E. Blackstein, Dennis A. Priebat, William D. Tap, Robert G. Maki, Christopher L. Corless, Jonathan A. Fletcher, Kouros Owzar, John J. Crowley, Robert S. Benjamin, Laurence H. Baker, Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. JAMA Oncology. ,vol. 3, pp. 944- 952 ,(2017) , 10.1001/JAMAONCOL.2016.6728

Jian-Xian Lin, Qing-Feng Chen, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Chang-Ming Huang, Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up. Journal of Cancer Research and Clinical Oncology. ,vol. 143, pp. 727- 734 ,(2017) , 10.1007/S00432-016-2334-X